Liposomes-entrapped chondroitin sulphate: Ultrastructural characterization and in vitro biocompatibility

Micron

Volumn 39, Issue 7, 2008, Pages 1042-1045

  Trif, Mihaela ^a   Moldovan, Lucia ^b   Moisei, Magdalena ^a   Craciunescu, Oana ^b   Zarnescu, Otilia ^c  

^a INSTITUTE OF BIOCHEMISTRY OF THE ROMANIAN ACADEMY   (Romania)

^b NATIONAL INSTITUTE OF RESEARCH AND DEVELOPMENT FOR BIOLOGICAL SCIENCES   (Romania)

^c UNIVERSITY OF BUCHAREST   (Romania)

Author keywords

Biocompatibility; Chondroitin sulphate; Liposomes; Ultrastructure

Indexed keywords

BIOCOMPATIBILITY; CELL CULTURE; CONTROL SYSTEMS; FIBROBLASTS; PHOSPHOLIPIDS; TISSUE;

CHONDROITIN SULPHATE (CS); COMPARATIVE STUDIES; CYTOTOXIC EFFECTS; ELECTRON-DENSE PARTICLES; HUMAN DERMAL FIBROBLAST (HDF); IN VITRO BIOCOMPATIBILITY; INFLAMMATORY DISORDERS; LIGHT MICROSCOPY (LM); THIN SECTIONS;

LIPOSOMES;

CHONDROITIN SULFATE; LIPOSOME;

ARTICLE; CELL CULTURE; CYTOLOGY; DRUG DELIVERY SYSTEM; FIBROBLAST; HUMAN; METABOLISM; POLARIZATION MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

CELLS, CULTURED; CHONDROITIN SULFATES; DRUG DELIVERY SYSTEMS; FIBROBLASTS; HUMANS; LIPOSOMES; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, POLARIZATION;

EID: 48749118292     PISSN: 09684328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micron.2008.01.008     Document Type: Article

References (15)

1. Ernst S., Langer R., Cooney C.L., and Sasisekharan R. Enzymatic degradation of glycosaminoglycans. Crit. Rev. Biochem. Mol. Biol. 30 (1995) 387-444
2. Fioravanti A., and Collodel G. In vitro effects of chondroitin sulfate. Adv. Pharmacol. 53 (2006) 449-465
3. Gabizon A., and Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. USA 85 (1988) 6949-6953
4. Hathout R.M., Mansour S., Mortada N.D., and Guinedi A.S. Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS Pharm. Sci. Tech. 8 (2007) E1-E12
5. Khalil I.A., Kogure K., Akita H., and Harashima H. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol. Rev. 58 (2006) 32-45
6. Khosravi-Darani K., Pardakhty A., Honarpisheh H., Rao V.S., and Mozafari M.R. The role of high-resolution imaging in the evaluation of nanosystems for bioactive encapsulation and targeted nanotherapy. Micron 38 (2007) 804-818
7. Kosaraju S.L., Tran C., and Lawrence A. Liposomal delivery systems for encapsulation of ferrous sulfate: preparation and characterization. J. Liposome Res. 16 (2006) 347-358
8. Metselaar J.M., and Storm G. Liposomes in the treatment of inflammatory disorders. Expert Opin. Drug Deliv. 2 (2005) 465-476
9. Olsson U., Camejo G., and Bondjers G. Binding of a synthetic apolipoprotein B-100 peptide and peptide analogues to chondroitin 6-sulfate: effects of the lipid environment. Biochemistry 32 (1993) 1858-1865
10. Prabhakar V., and Sasisekharan R. The biosynthesis and catabolism of galactosaminoglycans. Adv. Pharmacol. 53 (2006) 69-115
11. Raviv U., Needleman D.J., Li Y., Miller H.P., Wilson L., and Safinya C.R. Cationic liposome-microtubule complexes: pathways to the formation of two-state lipid-protein nanotubes with open or closed ends. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 11167-11172
12. Sihorkar V., and Vyas S.P. Potential of polysaccharide anchored liposomes in drug delivery, targeting and immunization. J. Pharm. Pharm. Sci. 4 (2001) 138-158
13. Torchilin V.P. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 4 (2005) 145-160
14. Trif M., Guillen C., Vaughan D.M., Telfer J.M., Brewer J.M., Roseanu A., and Brock J.H. Liposomes as possible carriers for lactoferrin in the local treatment of inflammatory diseases. Exp. Biol. Med. (Maywood, NJ) 226 (2001) 559-564
15. Uebelhart D., Knols R., de Bruin E.D., and Verbruggen G. Treatment of knee osteoarthritis with oral chondroitin sulfate. Adv. Pharmacol. 53 (2006) 523-539